Skip to main content
Log in

Adjuvant endocrine therapy of breast cancer

  • Scandinavian Breast Cancer Symposium
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schinzinger A: Über Carcinoma mammae. Verh Dtsch Ges Chir 18: 28, 1889.

    Google Scholar 

  2. Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2: 104, 1896.

    Google Scholar 

  3. De Courmelles F: La radiothérapie combinée du sein et des ovaires contre les tumeurs du sein. CR Acad Sci (Paris) 174: 503, 1922.

    Google Scholar 

  4. Cole MP: Suppression of ovarian function in primary breast cancer.In APM Forrest and PB Kunkler (eds). Prognostic Factors in Breast Cancer. Livingstone, 1968, pp 146–156.

  5. Nissen-Meyer R: Suppression of ovarian function in primary breast cancer.In APM Forrest and PB Kunkler (eds). Prognostic Factors in Breast Cancer. Livingstone, 1968, pp 139–145.

  6. Ravdin RG, Lewison EF, Slack NH, Gardner B, State D, Fisher B: Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg Gynecol Obstet 131: 1055–1064, 1970.

    Google Scholar 

  7. Nissen-Meyer R: Prophylactic endocrine treatment in carcinoma of the breast. Clin Radiol 15: 152–160, 1964.

    Google Scholar 

  8. Meakin JW, Allt WEC, Beale FA, Brown TC, Bush RS, Clark RM, Fitzpatrick PJ, Hawkins NV, Jenkin RDT, Pringle JF, Reid JG, Rider WD, Hayward JL, Bulbrook RD: Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. Canad Med Assoc J 120: 1221–1229, 1979.

    Google Scholar 

  9. Dao TL, Nemoto T, Chamberlain A, Bross I: Adrenalectomy with radical mastectomy in the treatment of high-risk breast cancer. Cancer 35: 478–482, 1975.

    Google Scholar 

  10. Prudente A: Postoperative prophylaxis of recurrent mammary cancer with testosterone propionate. Surg Gynecol Obstet 80: 575–592, 1945.

    Google Scholar 

  11. Bulbrook RD, Hayward JL: The possibility of predicting the response of patients with early breast cancer to subsequent endocrine ablation. Cancer Res 25: 1135–1139, 1965.

    Google Scholar 

  12. Hubay CA, Pearson OH, Marshall JS, Stellato TA, Rhodes RS, DeBanne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL and 27 Participating Investigators: Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trial. Breast Cancer Res Treat 1: 77–82, 1981.

    Google Scholar 

  13. Palshof T: Adjuvant endocrine therapy. Canad J Surg 24: 379–384, 1981.

    Google Scholar 

  14. Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias EG, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H, and other NSABP investigators: Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305: 1–11, 1981.

    Google Scholar 

  15. Baum M, Barnes DM, Brinkley D, Dossett JA, Ellis S, Holdaway IM, King RJB, Lea J, Leake R, McPherson K, Nicholson R, Patterson J, Richards D, Rubens RD, Smiddy FG, Stoll BA, Wilson AJ: UK multicentre adjuvant Nolvadex (tamoxifen) trial (in preparation).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubens, R.D. Adjuvant endocrine therapy of breast cancer. Breast Cancer Res Tr 2, 407–410 (1982). https://doi.org/10.1007/BF01805884

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01805884

Keywords

Navigation